These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 2527597)
1. Aromatase inhibitors in the treatment of advanced breast cancer. Miller WR Cancer Treat Rev; 1989 Jun; 16(2):83-93. PubMed ID: 2527597 [No Abstract] [Full Text] [Related]
2. Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer. Pérez N; Borja J J Int Med Res; 1992 Aug; 20(4):303-12. PubMed ID: 1387368 [TBL] [Abstract][Full Text] [Related]
3. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. Mauri D; Pavlidis N; Polyzos NP; Ioannidis JP J Natl Cancer Inst; 2006 Sep; 98(18):1285-91. PubMed ID: 16985247 [TBL] [Abstract][Full Text] [Related]
4. Use of aromatase inhibitors in postmenopausal women with advanced breast cancer. Roseman BJ; Buzdar AU; Singletary SE J Surg Oncol; 1997 Nov; 66(3):215-20. PubMed ID: 9369969 [TBL] [Abstract][Full Text] [Related]
5. Endocrine and clinical aspects of new compounds for treatment of hormone-related cancer in gynecology. von Matthiessen H; Distler W Recent Results Cancer Res; 1990; 118():190-5. PubMed ID: 2146725 [No Abstract] [Full Text] [Related]
7. Experience with aromatase inhibitors in the treatment of advanced breast cancer. Höffken K Cancer Treat Rev; 1993 Apr; 19 Suppl B():37-44. PubMed ID: 8481933 [TBL] [Abstract][Full Text] [Related]
8. Aromatase, its inhibitors and their use in breast cancer treatment. Brodie AM Pharmacol Ther; 1993 Dec; 60(3):501-15. PubMed ID: 8073072 [TBL] [Abstract][Full Text] [Related]
9. Recent progress in development of aromatase inhibitors. Santen RJ J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1029-35. PubMed ID: 2149503 [TBL] [Abstract][Full Text] [Related]
10. Aromatase inhibitors come of age. Dowsett M Ann Oncol; 1997 Jul; 8(7):631-2. PubMed ID: 9296213 [No Abstract] [Full Text] [Related]
11. Aminoglutethimide and ketoconazole: historical perspectives and future prospects. Shaw MA; Nicholls PJ; Smith HJ J Steroid Biochem; 1988 Jul; 31(1):137-46. PubMed ID: 2969435 [TBL] [Abstract][Full Text] [Related]
14. Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer. Lønning PE; Dowsett M; Powles TJ J Steroid Biochem; 1990 Mar; 35(3-4):355-66. PubMed ID: 2139151 [TBL] [Abstract][Full Text] [Related]
15. A summary of second-line randomized studies of aromatase inhibitors. Buzdar AU J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):109-14. PubMed ID: 11850214 [TBL] [Abstract][Full Text] [Related]
16. Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer. Buzdar A; Howell A Clin Cancer Res; 2001 Sep; 7(9):2620-35. PubMed ID: 11555572 [No Abstract] [Full Text] [Related]
17. Aromatase inhibitors and the treatment of breast cancer. Brodie AM; Wing LY; Goss P; Dowsett M; Coombes RC J Steroid Biochem; 1986 Jan; 24(1):91-7. PubMed ID: 3702431 [TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibition with 4-OHAndrostenedione after prior aromatase inhibition with aminoglutethimide in women with advanced breast cancer. Murray R; Pitt P Breast Cancer Res Treat; 1995 Sep; 35(3):249-53. PubMed ID: 7579495 [TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced breast cancer with formestane. Murray R; Pitt P Ann Oncol; 1994; 5 Suppl 7():S11-3. PubMed ID: 7873455 [TBL] [Abstract][Full Text] [Related]